GLSI

GREENWICH LIFESCIENCES, INC.

GLSI · CIK 1799788 · Annual (10-K) · Last 5 years

Financial Trends

Revenue
20202024
Net Income−$16M
20202024
Operating CF−$7M
20202024
Free Cash Flow
20202024

Income Statement

MetricFY 2024FY 2023FY 2022FY 2021FY 2020
Revenue
Cost of Revenue
Gross Profit
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.21$-0.69$-0.61
EPS (Diluted)$-1.21$-0.69

Balance Sheet

MetricFY 2024FY 2023FY 2022FY 2021FY 2020
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow
Capital Expenditures
Financing Cash Flow$0.0B$-0.0B$-0.0B$0.0B$0.0B